C. difficile Update Kim Vermedal, RN, MSN, CIC APIC January 25, 2019.

Slides:



Advertisements
Similar presentations
PREVENTION OF CATHETER ASSOCIATED URINARY TRACT INFECTIONS (CAUTIs)
Advertisements

Clostridium Difficile Infectious Diarrhea
Clostridium difficile Presented by Nate Smith, MD, MPH Carole Yeung, RN CIC.
Clostridium Difficile (C.diff): Fast Facts. What is Clostridium difficile (C. diff)? C. diff is a bacteria that lives in the intestinal tract of about.
Antimicrobial Resistance in Hospitals: Lack of Effective Treatment for Gram Negative Bacilli and the Rise of Resistant Clostridium difficile Infections.
Preventing Multi-Drug Resistant Organism (MDRO) Infections For National Patient Safety Goal
Giardia Lamblia. Giardia Giardia lamblia is a flagellated protozoan that infects the duodenum and small intestine. range from asymptomatic colonization.
Supporting people in Dorset to lead healthier lives C-difficile Care Home Conference November 2014 Infection Prevention and Control Norovirus How to spot.
C. Difficile and Fecal Microbiota Therapy
2013 CLOSTRIDIUM DIFFICILE EDUCATIONAL AND CONSENSUS CONFERENCE March 11-12, 2013.
New CLOSTRIDIUM DIFFICILE CDI Prevention Bundles
Management of Clostridium difficile Infections
1 What’s All the Fuss About Clostridium difficile? Peter C. Iwen, PhD, D(ABMM) Nebraska Public Health Laboratory
Monday AM report
Clostridium difficile Prevention and Treatment Katrina Beining & Christina Gardner Introduction Clostridium difficile (C. diff) is a gram-positive, spore-forming.
What’s All the Fuss About Clostridium difficile? Peter C. Iwen, PhD, D(ABMM) Nebraska Public Health Laboratory.
Sarah Galang and Brian Cupitt
Physicians: Infection Prevention is in YOUR Hands
Infection Prevention & Control for Physicians Infection Prevention & Control Department (TH 9am-5pm M-F) (HJD 9am-5pm M-F)
Outline C. difficile infection Fecal microbiota
Preventing Transmission of C. difficile: Practice Elise Tamplin, M(ASCP), MPH, CIC Brigham & Women’s Hospital.
Preventing and Treating C.difficile Lisa Casey, M.D. Assistant Professor, UT Southwestern Medical Center TSGE / SGNA Annual Scientific Meeting September.
Diarrhea Kriss Petrounov | Simeon Wong. What is Diarrhea  Originated from the Greek, διὰρροια meaning "a flowing through“  Explosion of poo and liquid.
Clostridium Difficile BY: KELSEY COMBS AND ROSA CORDOVA.
Lec. No. 11 Dr. Manahil Clostridium difficile C. difficile is a gram positive, spore forming, obligate anaerobe. Colonies of the organism are about 4mm.
Jane Stockley Chris Catchpole Carole Clive November 2012.
Giardiasis Giardia Enteritis Lambliasis Beaver Fever.
Clostridium Difficile Infection:
R3 민준기 Pf. 이창균. Introduction 1978 – Clostridium difficile major cause of diarrhea – Pseudomembranous colitis associated with the use of antimicrobial.
Clostridium difficile infections
Don’t Let Your Sinus Infection Turn Into a Life Threatening Colon Infection.
© 2013 Pearson Education, Inc. Bell Ringer  What is an endospore, and what special characteristics do endospore forming bacteria have?
JAMA Internal Medicine May 2015 Volume 175, Number5 R1 조한샘 / Prof. 이창균.
How I deal with an outbreak? Prof Bertrand SOUWEINE Medical ICU Clermont-Ferrand France ISICEM March 2009.
Assessment of Risk-Factors for Development of Clostridium Difficile Infection in Post-Surgical Patients SCOTT BATTLE UIC SCHOOL OF PUBLIC HEALTH.
Clostridium difficile Infection Fellow 이시내. Clostridium difficile  An anaerobic gram-positive, spore-forming, toxin-producing bacillus.  Transmitted.
Antimicrobial Stewardship
Reducing the Risk of Clostridium difficile Infection:
Clostridium Difficile Patients In the Endoscopy Center
Clostridium difficile Infection Biology & Public Health Impact
Clostridium difficle Isolation precautions
APIC Chapter 13 Journal Club
From: Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile InfectionA Randomized Trial Ann Intern Med.
C. difficile Detection and the Importance of Proper Specimen Collection and Testing [Name] [Title]
Dr Mustafa Nema /Baghdad college of Medicine 2014
Diseases caused by Staph. aureus
Improvement of management and reduction in mortality following implementation of audit recommendations in Clostridium difficile diarrhoea at James Cook.
Michelle Charles MSN, RN Karen Vallejo MSN, RN, CIC
Antimicrobial Resistance in Hospitals: Lack of Effective Treatment for Gram Negative Bacilli and the Rise of Resistant Clostridium difficile Infections.
HAI August 30, 2017.
HAI January 24, 2018.
APIC Chapter 13 Journal Club
Update on Clostridium difficile Infection
Portneuf Medical Center CAUTI Prevention Plan
HAI Sept. 25, 2017.
Management of Clostridium Difficile Infection
Diagnosed Food Handlers
Clostridium Difficile Infectious Diarrhea
C.Difficile update – what you need to know in Primary Care
Antibiotic Stewardship at MetroWest Medical Center
Treatment Update on Clostridium difficile Infection
Clostridium difficile Update
APIC Chapter 13 Meeting November 15, 2017 Question and Answer Session
Department of Aging and Disability Services
THE EFFECT OF BUNDLED INTERVENTIONS ON PREVENTION OF HOSPITAL ACQUIRED CLOSTRIDIUM DIFFICILE INFECTION Kaitlin M. Kendys BSN, RN DNP Student Significance.
March 9th, 2019 Brooke K. Decker, MD, CIC
Current Threats to Public Health
C. diff Testing Stewardship
Ohio Hospital Association Learning from Patient Stories
Salmonellosis Chapter 28: Infectious Diseases Lesson: 1&3
Presentation transcript:

C. difficile Update Kim Vermedal, RN, MSN, CIC APIC January 25, 2019

The Gut Microbiome & Disease Prevention Microbiome is a collection of 39 trillion microbes in our GI tract (predominantly the colon) Healthy microbiome protects the body from disease Preclude emergence of pathogens/MDRO’s Prevent changes to the microbial metabolome Preserve healthy gut function

Testing Multistep testing required One step testing-half of positives are not CDI 25% of CDI resolves on its own Do not test asymptomatic patients

Algorithm

Pediatric Testing High prevalence of asymptomatic carriage Never routinely recommended for neonates or infants < 12 months of age with diarrhea Should not be performed in children with diarrhea 1-2 years of age unless other infectious or non-infectious causes have been excluded

Antibiotic Stewardship IDSA Guidelines for decreased length of antibiotic therapies UK eliminated the most toxic subtype of C. difficile with stewardship (Fluorquinolones and Cephalosporin's) 41% increase in abx prescriptions in the outpatient setting by NP’s/PA’s. 15% decrease ordering by physicians

Community Acquired On the increase Usually less severe infection How is it spread in those patients without healthcare contact? 82% with outpatient exposure It's on surfaces 39.7% on shoe bottoms in one community study

Fecal Transplants Can prevent reoccurrence Many failures related to incorrect initial testing Trials in process to use for initial acute phase diagnosis In the near future-capsules

The Future is Close Vaccines in clinical trials New antibiotics with narrow spectrum focus 40 new antibiotics in development-only 1 in phase three trial stage Other compounds to maintain microbiome Extended tapers of Vancomycin-QOD FMT as primary treatment for CDI

SARMC Criteria for Testing Patient must have: ≥3 watery stools in the past 24 hrs (sample conforms to specimen container) Formed stool samples will be rejected. In rare suspicion of ileus/toxic megacolon 2ndary to C diff, consider rectal swab. AND At least 1 of the following: o Abdominal pain/discomfort (cramping, bloating) o Antibiotic therapy within last 3 months o Gastric acid suppression (proton pump inhibitor or H2 blocker) o GI surgery within last month o Resident of SNF, age >65 o Chemotherapy within last month o Hospitalization within last 2 months o C diff infection within last 90 days (unless tested within last 7 days or tested positive within last 30 days)

Criteria None of the following are applicable: Laxatives, Bowel prep or other current medications that are known to cause diarrhea within last 3 days TPN infusion Tube feedings Other infectious or parasitic sources of diarrhea are unlikely Acute resolution of bowel obstruction Expected post-operative diarrhea (post-operative day 0-2)--if unsure, clarify with provider Ileostomy or short bowel syndrome

Testing Algorithm Antigen/toxin testing first PCR if indicated Remember never order for test of cure

Removal for Isolation Has completed at least seven days of therapy Has formed stool Is capable of performing personal and hand hygiene with soap and water.

Questions?